Full CoverageTop news
The Drug That Could Revolutionize the Fight Against H.I.V.
By Jon Cohen
FDA approves new twice-yearly HIV shot. What to know
By Ken Alltucker
HIV: FDA Approves Highly Effective, Twice-Yearly Shot for Prevention
By Andrea Rice
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
By Logan Lutton & Peter Wehrwein
All coverage
Aliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment
By Samantha Fischer
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine Belt
By Jay Harrison
Here’s what everyone should know about this new HIV prevention shot
By Teddy Amenabar & Richard Sima
Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection
By Apoorva Mandavilli
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
By Laura Santhanam
Another tool in the fight against HIV — and more
By Lourdes Duarte, Patrick Elwood & Katharin Czink
FDA approves new HIV prevention drug
By Candice Bruce
Will Big Pharma Greed Consume Promise of 'HIV-Ending' Shot?
By Jessica Corbett
Groundbreaking twice-a-year HIV drug that could stop transmission approved
By Lauran Neergaard
FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.
By Josh Nathan-kazis
HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda
By Jonathan Lambert
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
By Annika Kim Constantino
US FDA approves Gilead's twice-yearly injection for HIV prevention
By Deena Beasley & Julie Steenhuysen
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
HIV protection with just two shots a year: FDA approves Gilead drug
By Ed Silverman & Jason Mast